JP2005529603A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529603A5 JP2005529603A5 JP2004512780A JP2004512780A JP2005529603A5 JP 2005529603 A5 JP2005529603 A5 JP 2005529603A5 JP 2004512780 A JP2004512780 A JP 2004512780A JP 2004512780 A JP2004512780 A JP 2004512780A JP 2005529603 A5 JP2005529603 A5 JP 2005529603A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- individual
- diabetic
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 6
- 229920001184 polypeptide Polymers 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 3
- 206010022489 Insulin Resistance Diseases 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000001280 Prediabetic State Diseases 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 210000000663 muscle cell Anatomy 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38871602P | 2002-06-13 | 2002-06-13 | |
| PCT/US2003/018976 WO2003105879A1 (en) | 2002-06-13 | 2003-06-13 | Compositions and methods for preventing, treating and diagnosing diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529603A JP2005529603A (ja) | 2005-10-06 |
| JP2005529603A5 true JP2005529603A5 (enExample) | 2006-07-27 |
Family
ID=29736528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004512780A Pending JP2005529603A (ja) | 2002-06-13 | 2003-06-13 | 糖尿病を予防、治療、および診断するための組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060210974A1 (enExample) |
| EP (1) | EP1511506A4 (enExample) |
| JP (1) | JP2005529603A (enExample) |
| AU (1) | AU2003238232A1 (enExample) |
| WO (1) | WO2003105879A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| JP5302012B2 (ja) | 2006-03-08 | 2013-10-02 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤 |
| JP5386350B2 (ja) | 2006-05-31 | 2014-01-15 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体 |
| WO2008079787A2 (en) | 2006-12-20 | 2008-07-03 | Takeda San Diego, Inc. | Glucokinase activators |
| US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
| JP2010540534A (ja) | 2007-09-28 | 2010-12-24 | イントレキソン コーポレーション | 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000069885A2 (en) * | 1999-05-14 | 2000-11-23 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
| WO2001066738A2 (en) * | 2000-03-06 | 2001-09-13 | Eli Lilly And Company | Nucleic acids, encoding human crsp1 and uses thereof |
-
2003
- 2003-06-13 AU AU2003238232A patent/AU2003238232A1/en not_active Abandoned
- 2003-06-13 WO PCT/US2003/018976 patent/WO2003105879A1/en not_active Ceased
- 2003-06-13 US US10/515,892 patent/US20060210974A1/en not_active Abandoned
- 2003-06-13 EP EP03737127A patent/EP1511506A4/en not_active Withdrawn
- 2003-06-13 JP JP2004512780A patent/JP2005529603A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mason et al. | Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats | |
| Inoue et al. | Sensitive detection of glycated albumin in human serum albumin using electrochemiluminescence | |
| CA2654733A1 (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
| CA2888743C (en) | Device and methods of using device for detection of aminoacidopathies | |
| CN103348015A (zh) | 用于分析物传感器的电极组合物 | |
| JP2016529515A (ja) | 高アンモニア血症の検出のためのデバイス及びデバイスを使用する方法 | |
| JP2004531224A5 (enExample) | ||
| JP2005529603A5 (enExample) | ||
| Bessman et al. | Sugar Electrode Sensor for the | |
| JP2005528921A5 (enExample) | ||
| KR950704001A (ko) | 인간 세로토닌 수용체(5-ht_4b)를 암호화하는 dna 및 그 용도 | |
| JP2005528080A5 (enExample) | ||
| JP2002515223A5 (enExample) | ||
| CN103267783A (zh) | 一种检测过氧化氢、尿酸或尿酸酶的方法 | |
| Xi et al. | Relationship between dilated cardiomyopathy and the E23K and I337V polymorphisms in the Kir6. 2 subunit of the K | |
| JP2006500002A5 (enExample) | ||
| Vaidya et al. | Use of charged membranes to control interference by body chemicals in a glucose biosensor | |
| JP2005525112A5 (enExample) | ||
| PRASAD | Glucagon-induced changes in the action potential, contraction, and Na+-K+-ATPase of cardiac muscle | |
| JP2005538930A5 (enExample) | ||
| JP2003514549A5 (enExample) | ||
| CN115181176A (zh) | RyR2基因突变、检测试剂盒、以及构建其动物模型的方法 | |
| KR102802646B1 (ko) | 시료 내 바이오마커를 이용하는 질병 자가 진단 장치 | |
| JP2007515940A5 (enExample) | ||
| JP2003532369A5 (enExample) |